Analgesics
This category showed growth of 8.8% in value and 4.9% in volume. Both Panado and Compral grow ahead of the category in value and volume.
Cough, colds, flu and congestion
LCC continued to show strong growth (12.6%), well ahead of the market
Energy supplements
Bioplus continues to lead the single sachet/application market in FMCG
Bioplus is growing at 15%, ahead of the market, in FMCG and show good growth in its market share
Gut Health
Probiflora retains the market leader spot in this segment of the market in FMCG. |
|
| • |
Market growth driven by growing middle class and the global trend towards self-care as consumers are becoming more educated |
| • |
Growth driven by new product formats and a focus on the prevention and treatment of lifestyle diseases |
| • |
Consumer expectations for improved healthcare are increasing with access to digital information making them far more knowledgeable about their health |
| • |
Current pressures on the consumer are forcing trading down to smaller pack sizes or cheaper alternatives making pack and price offerings more important |
| • |
More regulated environment resulting in increased compliance costs |
|
|
| • |
Continued investment in marketing to protect and build the core brands |
| • |
Expand non-regulated product portfolio via innovation and acquisition |
| • |
Stock and demand management |
| • |
Regulatory compliance, specifically CAMs |
|
|
| • |
Panado |
| • |
Bioplus |
| • |
Probiflora |
| • |
Compral |
| • |
Cepacol |
| • |
GynaGuard |
| • |
ViralGuard |
| • |
Gummy Vites |
| • |
Codral |
| • |
ArthroGuard |
|
